Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Healthcare ETF (IYH) Hits New 52-Week High


For investors seeking momentum, iShares U.S. Healthcare ETF IYH is probably on the radar. The fund just hit a 52-week high and has risen 23.24% from its 52-week low of $53.35 per share.

But, are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook to get a better idea of where it might head:

IYH in Focus

The underlying Russell 1000 Health Care RIC 22.5/45 Capped Gross Index measures the performance of the healthcare sector of the U.S. equity market. The product charges 38 bps in annual fees (See: All Health Care ETFs).

Why the Move?

Healthcare has picked up momentum lately, with investors seeking safety amid growing worries about AI overvaluation. The fund has allocated about 14.60% to Eli Lilly LLY, which briefly surpassed the $1 trillion market cap mark on Nov. 21, making it the first healthcare company to break into a club long ruled by tech heavyweights.

Additionally, the increasing adoption of AI in U.S. healthcare continues to provide a meaningful tailwind for the sector.

More Gains Ahead?

Currently, IYH has a Zacks ETF Rank #3 (Hold) with a High risk outlook. However, it might continue its strong performance in the near term, with a positive weighted alpha of 11.59 (as per Barchart.com), which gives cues of a further rally.

Boost Your Portfolio with Our Top ETF Insights

Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week.

Don’t miss out on this valuable resource. It’s free!

Get it now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Eli Lilly and Company (LLY): Free Stock Analysis Report
 
iShares U.S. Healthcare ETF (IYH): ETF Research Reports

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments